CDK4 and melanoma: Mutations of Pro to Leu, Thr, and Ser at position 5 lead to the loss of its binding with CDK4, which is associated with multiple sub-types of melanoma, non-small cell lung carcinoma, and head and neck tumors, as shown in Table 3.